About the PROTID Consortium

PROTID is a network of scientists and clinicians from institutes in the Netherlands, Uganda, Tanzania, United Kingdom and New Zealand. The consortium partners share an ambition to prevent TB among people with diabetes.

The project is coordinated by Radboudumc from Nijmegen, The Netherlands. Partner NIMR MMRC in Mbeya, Tanzania is sponsor of the trial.

Scientific Advisory Board

  PROTID’s Scientific Advisory Board (SAB) consists of five independent scientists who together act as an advisory capacity to review results and research plans, to provide the Executive Group with recommendations on the continuation and to safeguard the interest of the project.

Read more

Radboudumc

The Radboud university medical center (Radboudumc) is the Coordinator of the PROTID project and responsible for project management, capacity development and training, stakeholder engagement and dissemination.

Read more

NIMR-MMRC

NIMR-MMRC is the main lead for the trial management and sponsor of the multicenter randomized clinical trial on preventive treatment and the parallel prospective cohort study.

Read more

King’s College London

King’s Health Economics is working closely with SGUL on the economic evaluation Work Package.

Read more

Makerere University

Makerere University will lead the DM screening Work Package.

Read more

St George’s University of London

St George’s University is leading the economic evaluation Work Package.

Read more

KCMC

KCMC is leading the Work Package on preventive and therapeutic management of combined diabetes mellitus and TB

Read more

Lubaga Hospital

Uganda Martyrs Hospital Lubaga will be one of the main recruiting sites in Uganda.

Read more

University of Otago

The University of Otago is providing key TB epidemiological support.

Read more